Skip to main content
. 2011 Dec 7;2:244. doi: 10.3389/fmicb.2011.00244

Figure 3.

Figure 3

Comparison of Rapa/IL-10/specific peptide tolerization protocol using different routes of drug administration. DO.11.10-tg Rag−/− mice (n = 4/group) were treated for 3 weeks with Rapa/IL-10/ova-specific peptide, after which the spleens were harvested, and flow cytometry was used to determine: (A) percentage of CD4+ T cells of total gated splenocytes and (B) percentage of CD25+FoxP3+ cells of CD4+ T cells. Statistically significant differences between two groups are indicated as *P < 0.05 and **P < 0.01.